RecruitingNCT05548621
A Prospective Study to Evaluate the Implementation of Shared Decision Making Strategy for Renal Cell Cancer (RCC)
Sponsor
St. Antonius Hospital
Enrollment
180 participants
Start Date
Nov 24, 2022
Study Type
OBSERVATIONAL
Conditions
Summary
The aim of this study is to evaluate the effect of two decision aids for renal cell carcinoma (RCC) on the decision-making process and the quality of the decision.
Eligibility
Min Age: 18 Years
Plain Language Summary
Simplified for easier understanding
This study is looking at how well a "shared decision-making" approach works in practice for people with kidney cancer (renal cell carcinoma). Shared decision-making means the patient and doctor work together using special tools to choose the best treatment option.
**You may be eligible if...**
- You have been diagnosed with kidney cancer (renal cell carcinoma)
- You are facing a treatment decision about a small early-stage tumor or advanced/metastatic disease
- You have provided written informed consent
**You may NOT be eligible if...**
- You are unable to complete questionnaires or participate in an individual interview
Talk to your doctor to see if this trial is right for you.
This summary was AI-generated to explain the trial in plain language. It is not medical advice. Always discuss eligibility with your doctor before enrolling in a clinical trial.
Interested in this trial?
Get notified about updates and connect with the research team.
Interventions
OTHERDecision aid
Online interactive decision aid for RCC
Locations(1)
View Full Details on ClinicalTrials.gov
For the most up-to-date information, visit the official listing.
NCT05548621
Related Trials
Testing of Bevacizumab, Erlotinib, and Atezolizumab in Combination for Advanced-Stage Kidney Cancer
NCT0498150913 locations
A Clinical Study of Belzutifan and Zanzalintinib in People With Recurrent Kidney Cancer Following Adjuvant Therapy (MK-6482-033)
NCT07227402111 locations
A Study to Investigate Safety of AZD6750 in Adult Participants With Select Advanced or Metastatic Solid Tumors
NCT0711504313 locations
A First-in-Human Study of BMS-986506 in Participants With Advanced Clear Cell Renal Cell Carcinoma (ccRCC)
NCT071956829 locations
Comparison of In-Home Versus In-Clinic Administration of Subcutaneous Nivolumab Through Cancer CARE (Connected Access and Remote Expertise) Beyond Walls (CCBW) Program
NCT062652851 location